" /> Lymphoproliferative syndrome 1 - CISMeF





Preferred Label : Lymphoproliferative syndrome 1;

Symbol : LPFS1;

CISMeF acronym : LPFS1;

Type : Phenotype, molecular basis known;

Description : Lymphoproliferative syndrome-1 is an autosomal recessive primary immunodeficiency characterized by onset in early childhood of Epstein-Barr virus (EBV)-associated immune dysregulation, manifest as lymphoma, lymphomatoid granulomatosis, hemophagocytic lymphohistiocytosis, Hodgkin disease, and/or hypogammaglobulinemia. Autoimmune disorders, such as autoimmune hemolytic anemia or renal disease, may also occur. Patients show a high EBV viral load and decreased invariant natural killer T cells. It is unknown whether patients with ITK mutations are intrinsically susceptible to development of lymphoma or dysgammaglobulinemia in the absence of EBV infection (summary by Stepensky et al., 2011; Linka et al., 2012). For a discussion of genetic heterogeneity of lymphoproliferative syndrome, see XLP1 (308240).;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the IL2-inducible T-cell kinase gene (ITK, 186973.0001);

Neoplasia : Increased risk for lymphoma Hodgkin disease;

Laboratory abnormalities : Elevated erythrocyte sedimentation rate (ESR); Increased C-reactive protein; High EBV viral load;

Prefixed ID : #613011;

Details


You can consult :


Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.